Clinical Trial Update: Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating histamine, CGRP, and VIP as biomarkers for activation of trigeminal and parasympathetic nerve fibers in migraine and sinusitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Sinusitis

Snippet

Sponsor: Clinvest | Conditions: Migraine, Sinusitis | Phase 4 | Status: COMPLETED